Portal de Periódicos da CAPES

Fighting the War on Breast Cancer: Debates over Early Detection, 1945 to the Present

1998; American College of Physicians; Volume: 129; Issue: 1 Linguagem: Inglês

10.7326/0003-4819-129-1-199807010-00028

1539-3704

Barron H. Lerner,

Colorectal Cancer Screening and Detection

Medical Writings1 July 1998Fighting the War on Breast Cancer: Debates over Early Detection, 1945 to the PresentBarron H. Lerner, MD, PhDBarron H. Lerner, MD, PhDColumbia University; New York, NY 10032.Note: Opinions expressed in the article are those of the author.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-129-1-199807010-00028 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail The recent consensus meetings on screening mammography for women 40 to 49 years of age generated great controversy. Critics of the consensus statements, particularly the January 1997 decision by a National Institutes of Health (NIH) panel not to recommend routine screening, used language that was often vitriolic and accusatory [1-3].In attempting to explain why these efforts at consensus generated such antagonism, various commentators have convincingly argued that these debates were not really about the scientific value of mammography. Indeed, it has been claimed that there is broad agreement on what the data show [4]. Instead, as Fletcher [5], Ernster ...References1. Kolata G. Mammogram talks prove indefinite. New York Times. 24 January 1997:A1, A15. Google Scholar2. Kolata G. Stand on mammograms greeted by outrage. New York Times. 28 January 1997:C1, C8. Google Scholar3. Begley S. The mammogram war. Newsweek. 24 February 1997:54-8. Google Scholar4. Ransohoff DF, Harris RP. Lessons from the mammography screening controversy: can we improve the debate? Ann Intern Med. 1997; 127:1029-34. Google Scholar5. Fletcher SW. Whither scientific deliberation in health policy recommendations? Alice in the Wonderland of breast-cancer screening. N Engl J Med. 1997; 336:1180-3. Google Scholar6. Ernster VL. Mammography screening for women aged 40 through 49-a guidelines saga and a clarion call for informed decision making. Am J Public Health. 1997; 87:1103-7. Google Scholar7. Eddy DM. Breast cancer screening in women younger than 50 years of age: what's next? [Editorial] Ann Intern Med. 1997; 127:1035-6. Google Scholar8. Woolf SH, Lawrence RS. Preserving scientific debate and patient choice: lessons from the Consensus Panel on Mammography Screening. JAMA. 1997; 278:2105-8. Google Scholar9. Aronowitz R. To screen or not to screen: What is the question? [Editorial] J Gen Intern Med. 1995; 10:295-7. Google Scholar10. Sontag S. Illness as Metaphor. New York, NY: Farrar, Straus and Giroux; 1978:66. Google Scholar11. The Women's Field Army of the American Society for the Control of Cancer. There Shall Be Light! New York: New York City Cancer Committee; 1945. Google Scholar12. Black ME. What did popular women's magazines from 1929 to 1949 say about breast cancer? Cancer Nurs. 1995; 18:270-7. Google Scholar13. Strax P. Early Detection: Breast Cancer Is Curable. New York: Harper & Row; 1974:5, 80, 85. Google Scholar14. Haagensen CD. Diseases of the Breast. Philadelphia: WB Saunders; 1956: 522-30, 587. Google Scholar15. McDivitt RW. Detection and management of “early breast cancer.” Proc Natl Cancer Conf. 1972; 7:269-73. Google Scholar16. Ross WS. Crusade: The Official History of the American Cancer Society. New York: Arbor House; 1987:94-8. Google Scholar17. Fisher B. The evolution of paradigms for the management of breast cancer: a personal perspective. Cancer Res. 1992; 52:2371-83. Google Scholar18. Sanders-Goebel P. Crisis and controversy: historical patterns in breast cancer surgery. Canadian Bulletin of Medical History. 1991; 8:77-90. Google Scholar19. Crile G Jr. The smaller the cancer, the bigger the operation? JAMA. 1967; 199:146-53. Google Scholar20. MacDonald I. Biological predeterminism in human cancer. Surgery, Gynecology, and Obstetrics. 1951; 92:443-52. Google Scholar21. Park WW, Lees JC. The absolute curability of cancer of the breast. Surgery, Gynecology, and Obstetrics. 1951; 93:129-52. Google Scholar22. Black MM, Speer FD. Biologic variability of breast carcinoma in relation to diagnosis and therapy. New York State Journal of Medicine. 1953; 53:1560-3. Google Scholar23. McKinnon NE. Limitations in diagnosis and treatment of breast and other cancers. Can Med Assoc J. 1995; 73:614-625. Google Scholar24. Baum M. The history of breast cancer. In: Forbes JF, ed. Breast Disease. Edinburgh: Churchill Livingstone; 1986:95-105. Google Scholar25. Black WC, Welch HG. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med. 1993; 328:1237-43. Google Scholar26. Significance of statistical analysis of end-results in the treatment of breast cancer. In: Proceedings of the Second National Cancer Conference. vol. I. New York: American Cancer Society; 1952:114, 117-9, 123. Google Scholar27. MacDonald I. The individual basis of biologic variability in cancer. Surgery, Gynecology, and Obstetrics. 1958; 106:227-9. Google Scholar28. Crile G. Cancer and Common Sense. New York: Viking Press; 1955:7, 8. Google Scholar29. Strax P. The stationary death rate. In: Strax P, ed. Control of Breast Cancer through Mass Screening. Littleton, MA: PSG Publishing; 1979:6. Google Scholar30. Notkin LJ. The theory of biologic predeterminism: its questionable usefulness and validity as a medical tool. Can Med Assoc J. 1959; 81:190-1. Google Scholar31. Boyd DP. Biological predeterminism. Lahey Clin Found Bull. 1969; 18:135-6. Google Scholar32. A statement disagreeing with Dr. Crile. Life. 31 October 1955:129. Google Scholar33. Patterson JT. The Dread Disease: Cancer and Modern American Culture. Cambridge, MA: Harvard Univ Pr; 1987:137-51, 244-54. Google Scholar34. Proctor RN. Cancer Wars: How Politics Shapes What We Know and Don't Know about Cancer. New York: Basic Books; 1995. Google Scholar35. Fechner RE. One century of mammary carcinoma in situ. What have we learned? Am J Clin Pathol. 1993; 100:654-61. Google Scholar36. Broders AC. Carcinoma in situ contrasted with benign penetrating epithelium. JAMA. 1932; 99:1671-5. Google Scholar37. Snyder RE. Mammography and lobular carcinoma in situ. Surgery, Gynecology, and Obstetrics. 1966; 122:255-60. Google Scholar38. Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson IC. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA. 1996; 275:913-8. Google Scholar39. Cady B, Stone MD, Schuler JG, Thakur R, Wanner MA, Lavin PT. The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg. 1996; 131:301-8. Google Scholar40. Haagensen CD, Lane N, Lattes R, Bodian C. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer. 1978; 42:737-69. Google Scholar41. Lewison EF. Lobular carcinoma in situ of the breast: the feminine mystique. Mil Med. 1964; 129:115-23. Google Scholar42. Brody JE, Holleb AI. You Can Fight Cancer and Win. New York: Quadrangle; 1977:136. Google Scholar43. Newman W. Lobular carcinoma of the female breast. Report of 73 cases. Ann Surg. 1966; 164:305-14. Google Scholar44. Farrow JH. Current concepts in the detection and treatment of the earliest of the early breast cancers. Cancer. 1970; 25:468-77. Google Scholar45. Kilgore AR. The incidence of cancer in the second breast. JAMA. 1921; 77:454-7. Google Scholar46. Hubbard TB. Nonsimultaneous bilateral carcinoma of the breast. Surgery. 1953; 34:706-23. Google Scholar47. McDivitt RW, Hutter RV, Foote FW Jr, Stewart FW. In situ lobular carcinoma. A prospective follow-up study indicating cumulative patient risks. JAMA. 1967; 201:82-6. Google Scholar48. Qualheim RE, Gall EA. Breast carcinoma with multiple sites of origin. Cancer. 1957; 10:460-8. Google Scholar49. Warner NE. Lobular carcinoma of the breast. Cancer. 1969; 23:840-6. Google Scholar50. Hutter RV, Foote FW Jr. Lobular carcinoma in situ. Long term follow-up. Cancer. 1969; 24:1081-5. Google Scholar51. Leis HP Jr, Mersheimer WL, Black MM, Chabon AD. The second breast. New York State Journal of Medicine. 1965; 65:2460-8. Google Scholar52. Wheeler JE, Enterline HT, Roseman JM, Tomasulo JP, McIlvaine CH, Fitts WT Jr, et al. Lobular carcinoma in situ of the breast. Long-term followup. Cancer. 1974; 34:554-63. Google Scholar53. Urban JA. Bilaterality of cancer of the breast. Biopsy of the opposite breast. Cancer. 1967; 20:1867-70. Google Scholar54. Benfield JR, Fingerhut AG, Warner NE. Lobular carcinoma of the breast-1969. A therapeutic proposal. Arch Surg. 1969; 99:129-40. Google Scholar55. Wanebo HJ, Huvos AG, Urban JA. Proceedings: Treatment of minimal breast cancer. Cancer. 1974; 33:349-57. Google Scholar56. Rosen PP, Braun DW Jr, Lyngholm B, Urban JA, Kinne DW. Lobular carcinoma in situ of the breast: preliminary results of treatment by ipsilateral mastectomy and contralateral breast biopsy. Cancer. 1981; 47:813-9. Google Scholar57. Perez FM. Speculations: some suggestions to control breast cancer. Med Times. 1974; 102:147-9, 152, 154-6, 158, 160. Google Scholar58. Fredricks S. A 10-year experience with subcutaneous mastectomy. Clin Plast Surg. 1975; 2:347-57. Google Scholar59. Chen E. Some trying surgery as preventive. Los Angeles Times. 9 December 1980:1, 17-8. Google Scholar60. Black MM, Barclay TH, Cutler SJ, Hankey BF, Asire AJ. Association of atypical characteristics of benign breast lesions with subsequent risk of breast cancer. Cancer. 1972; 29:338-43. Google Scholar61. Fox MS. On the diagnosis and treatment of breast cancer. JAMA. 1979; 241:489-94. Google Scholar62. Grooff PN, Pamies RJ, Hunyadi S. Lobular carcinoma in situ: what clinicians need to know. Hosp Pract (Off Ed). 1993; 28:122, 125, 129-30. Google Scholar63. Carson W, Sanchez-Forgach E, Stomper P, Penetrante R, Tsangaris TN, Edge SB. Lobular carcinoma in situ: observation without surgery as an appropriate therapy. Ann Surg Oncol. 1994; 1:141-6. Google Scholar64. Love SM, Lindsey K. Dr. Susan Love's Breast Book. Reading, MA: Addison-Wesley; 1990. Google Scholar65. Fugh-Berman A. Tamoxifen on trial: the high risks of prevention. Nation. 21 December 1992:757, 770, 772. Google Scholar66. Altman R. Waking Up, Fighting Back: The Politics of Breast Cancer. Boston: Little, Brown; 1996:169-83, 200-14. Google Scholar67. Plotkin D. Good news and bad news about breast cancer. The Atlantic Monthly. June 1996:53-5, 58, 60, 62-3, 66-70, 72-4, 76, 78, 81-2. Google Scholar68. Bailar JC 3d, Gomik HL Cancer undefeated. N Engl J Med. 1997; 336:1569-74. Google Scholar69. Kramer BS, Klausner RD. Grappling with cancer-defeatism versus the reality of progress. N Engl J Med. 1997; 337:931-4. Google Scholar70. Hellman S. Stopping metastases at their source [Editorial]. N Engl J Med. 1997; 337:996-7. Google Scholar71. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin. 1997; 47:5-27. Google Scholar72. Subalt-Sharpe G. Is mammography safe? Yes, no and maybe. New York Times Magazine. 24 October 1976:42-5. Google Scholar73. Kushner R. Is aggressive adjuvant chemotherapy the Halsted radical of the '80s? CA Cancer J Clin. 1984; 34:345-51. Google Scholar74. Nattinger AB, Hoffman RG, Shapiro R, Gottlieb MS, Goodwin JS. The effect of legislative requirements on the use of breast-conserving surgery. N Engl J Med. 1996; 335:1035-40. Google Scholar75. Brown J. The Definition of a Profession: The Authority of Metaphor in the History of Intelligence Testing, 1890-1930. Princeton, NJ: Princeton Univ Pr; 1992:139. Google Scholar76. Rosen M. Mission possible: a cancer survivor fights back. Good Housekeeping. 1997; April:30. Google Scholar77. Snowe O. Snowe: America must declare war on breast cancer. Congressional Press Releases. 13 June 1996. Google Scholar78. Stabiner K. To Dance with the Devil: The New War on Breast Cancer. New York: Delacorte Pr; 1997:3-19. Google Scholar79. http://www.fight-breastcancer.com/. Google Scholar80. The new war on breast cancer. MacLean's. 11 July 1994:42-4. Google Scholar81. Shalala D. Breast cancer war must go on. Chicago Tribune. 5 March 1995:6. Google Scholar82. Chambliss L. Battling breast cancer at work. Working Woman. 1995; October:74-6. Google Scholar83. Powell M, Levine S. New players join the race for the cure: black women see apt cause in fight against breast cancer. Washington Post. 8 June 1997:B1. Google Scholar84. Coulton A. Spiegel card rebates can go to war on breast cancer. American Banker. 18 August 1997:12. Google Scholar85. Vendantam S. Scientists plan to use $30 million in search of new cancer genes. Houston Chronicle. 2 November 1996:A6. Google Scholar86. Waldholz M. A cancer survivor's genetic time bomb. Wall Street Journal. 10 November 1997:B1, B13. Google Scholar87. Weber B. Breast cancer susceptibility genes: current challenges and future promises [Editorial]. Ann Intern Med. 1996; 124: 1088-90. Google Scholar88. Collins FS. BRCA1-lots of mutations, lots of dilemmas [Editorial]. N Engl J Med. 1996; 334:186-8. Google Scholar89. Burke W, Daly M, Garber J, Botkin J, Kahn MJ, Lynch P, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Study Consortium. JAMA. 1997; 277:997-1003. Google Scholar90. Healy B. BRCA genes-bookmaking, fortunetelling, and medical care [Editorial]. N Engl J Med. 1997; 336:1448-9. Google Scholar91. Couch FJ, DeShano ML, Blackwood MA, Calzone K, Stopfer J, Campeau L, et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med. 1997; 336:1409-15. Google Scholar92. Krainer M, Silva-Arrieta S, FitzGerald MG, Shimada A, Ishioka C, Kanamaru R, et al. Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. N Engl J Med. 1997; 336:1416-21. Google Scholar93. Jonsen AB, Durfy SJ, Burke W, Motulsky AG. The advent of the “unpatients.” Nat Med. 1996; 2:622-4. Google Scholar94. Schrag D, Kuntz KM, Garber JE, Weeks JC. Decision analysis-effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med. 1997; 336:1465-71. Google Scholar Author, Article, and Disclosure InformationAuthors: Barron H. Lerner, MD, PhDAffiliations: Columbia University; New York, NY 10032.Note: Opinions expressed in the article are those of the author.Acknowledgments: The author thanks H. Gilbert Welch, Hiram S. Cody, Phillip I. Lerner, David J. Rothman, Jonathan H. Sadowsky, Freya R. Schnabel, and Steven Shea for their advice.Grant Support: In part by the Arnold P. Gold Foundation and the Burroughs Wellcome Fund. Dr. Lerner is a Robert Wood Johnson Foundation Generalist Physician Faculty Scholar (Project # 031491).Corresponding Author: Barron H. Lerner, MD, PhD, Department of Medicine, Columbia University, College of Physicians & Surgeons, Box 11, 630 West 168th Street, New York, NY 10032. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoApplying World Wide Web Technology to the Study of Patients with Rare Diseases Piet C. de Groen , Jon A. Barry , and William J. Schaller Fighting the War on Breast Cancer Maryann Napoli Fighting the War on Breast Cancer Barron H. Lerner Celebrating the ACP Centennial: From the Annals Archive—Breast Cancer Screening Deborah Cotton Metrics Cited byUnderstanding professional stakeholders’ active resistance to guideline implementation: The case of Canadian breast screening guidelinesEthical and Societal Considerations in Breast Cancer ScreeningCelebrating the ACP Centennial: From the Annals Archive—Breast Cancer ScreeningDeborah Cotton, MD, MPH, Deputy EditorCancer Screening: The Journey from Epidemiology to PolicyIntroductionReading and WritingCuttingDiagnosingCuratingTestifying and TeachingExpositionNotesBibliography‘That's like chopping off a finger because you’re afraid it might get broken’: Disease and illness in women's views of prophylactic mastectomyConstructing “High-Risk Women”: The Development and Standardization of a Breast Cancer Risk Assessment ToolAverage-risk ScreeningInventing a Curable Disease: Historical Perspectives on Breast CancerBREAST CANCER SCREENINGGreat expectations: historical perspectives on genetic breast cancer testing.Fighting the War on Breast CancerMaryann Napoli 1 July 1998Volume 129, Issue 1Page: 74-78KeywordsArmed forcesBiopsyBreast cancerCancer treatmentForecastingInvasive lobular carcinomaLesionsMammographySurgeonsSurgery ePublished: 15 August 2000 Issue Published: 1 July 1998 Copyright & PermissionsCopyright © 1998 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...